Clinical Trial Update: Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy [Phase 2]

View source ↗

Summary

This document updates a Phase 2 trial evaluating Adebrelimab with Famitinib and Irinotecan for advanced gastric cancer after first-line therapy failure; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Famitinib (Famitinib)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Shandong Tumor Hospital | Conditions: Stomach Neoplasms | Phase 2 | Status: RECRUITING